Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-binding proteins in cancer drug discovery
Jean B. Bertoldo, Simon Müller, Stefan Hüttelmaier
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103580-103580
Closed Access | Times Cited: 20

Showing 20 citing articles:

Cytoplasmic Regulation of the Poly(A) Tail Length as a Potential Therapeutic Target
Mercedes Fernández, Raúl Méndez
RNA (2025), pp. rna.080333.124-rna.080333.124
Closed Access
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer
Viola Melone, Domenico Palumbo, Luigi Palo, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Small molecule inhibition of RNA binding proteins in haematologic cancer
Amit Jaiswal, Michelle L. Thaxton, Georgia Scherer, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-14
Open Access | Times Cited: 3
Fates and functions of RNA‐binding proteins under stress
Binita Goswami, Sharanya Nag, Partho Sarothi Ray
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth
Opeyemi Olotu, Anna-Riina Koskenniemi, Lin Ma, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114430-114430
Open Access | Times Cited: 1
ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancer
Chengguo Li, Yuping Yin, Ruikang Tao, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
IGF2BP1—An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation
Markus Glaß, Stefan Hüttelmaier
Viruses (2023) Vol. 15, Iss. 7, pp. 1431-1431
Open Access | Times Cited: 2
Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice
Sadeeshkumar Velayutham, Ryan Seerattan, Maab Sultan, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1276-1276
Open Access | Times Cited: 2
Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis.
Wenchao Zhang, Rong He, Wenbing Cao, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5094-5121
Closed Access | Times Cited: 2
NANOS1 restricts oral cancer cell motility and TGF-ß signaling
Julia Rosemann, Jonas Pyko, Roland Jacob, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151400-151400
Open Access
ZCCHC17 knockdown phenocopies Alzheimer’s disease-related loss of synaptic proteins and hyperexcitability
Giuseppe P. Cortese, Anne Marie W. Bartosch, Harrison Xiao, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 7, pp. 626-635
Closed Access
Recent Advances on Bioactive Molecules Acting on RNA and RNA Binding Proteins
Abhya Bhardwaj -, Neelmani, Charanjit Kaur
International Journal For Multidisciplinary Research (2024) Vol. 6, Iss. 3
Open Access
LINC00513 promotes colorectal cancer malignant progression by binding with IGF2BP1 to enhance the stability of connective tissue growth factor mRNA
Weijian Lun, Xiaobin Zhang, Yinsheng Hong, et al.
Epigenomics (2024) Vol. 16, Iss. 14, pp. 985-998
Closed Access
Correlation with Apoptosis Process through RNA-Seq Data Analysis of Hep3B Hepatocellular Carcinoma Cells Treated with Glehnia littoralis Extract (GLE)
Min Yeong Park, Sujin Lee, Hun Hwan Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9462-9462
Open Access
Identification of an RNA-binding perturbing characteristic for thiopurine drugs and their derivatives to disrupt CELF1–RNA interaction
Yang Tan, Zhibo Zhao, Qingfang Han, et al.
Nucleic Acids Research (2024)
Open Access
Drug Discovery
Manos C. Vlasiou
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 1-16
Closed Access
Targeting RNA-protein interactions with small molecules: promise and therapeutic potential
Curran A. Rhodes, Sumirtha Balaratnam, Kamyar Yazdani, et al.
Medicinal Chemistry Research (2024)
Open Access
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin
Jingxuan Wang, Lisi Zheng, Wanqi Chen, et al.
Oncogene (2024)
Closed Access
New therapeutic approaches for fibrosis: harnessing translational regulation
S.S. Gill, Richard H. Gomer
Trends in Molecular Medicine (2024)
Closed Access
Novel Anti-melanoma Leads Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice
Sadeeshkumar Velayutham, Ryan Seerattan, Maab Sultan, et al.
(2023)
Open Access | Times Cited: 1
Role of the RNA-binding protein family in gynecologic cancers.
Linlin Hao, Jian Zhang, Zhongshan Liu, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3799-3821
Closed Access
Page 1

Scroll to top